JTCS Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kempsford, R. D.
Right arrow Articles by Hearse, D. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kempsford, R. D.
Right arrow Articles by Hearse, D. J.

The Journal of Thoracic and Cardiovascular Surgery, Vol 97, 856-863, Copyright © 1989 by The American Association for Thoracic Surgery and The Western Thoracic Surgical Association


ARTICLES

Protection of the immature myocardium during global ischemia. A comparison of four clinical cardioplegic solutions in the rabbit heart

RD Kempsford and DJ Hearse
Cardiovascular Research, Rayne Institute, St. Thomas' Hospital, London, England.

Controversy surrounds the reported beneficial effects of crystalloid cardioplegic solutions in the immature myocardium. In the present study we have investigated the efficacy of four clinical cardioplegic solutions in the immature myocardium to determine (1) whether cardioplegic protection could be demonstrated and, if so, (2) the relative efficacy of the four solutions. Isolated, working hearts (n = 6 per group) from neonatal rabbits (aged 5 to 8 days) were perfused aerobically (37 degrees C) for 20 minutes before a 2-minute infusion of one of four cardioplegic solutions: The St. Thomas' Hospital No. 2, Tyers, Bretschneider, and Roe solutions. Hearts were then rendered globally ischemic for 50 minutes at 37 degrees C before reperfusion for 15 minutes in the Langendorff mode and 20 minutes in the working mode. The postischemic recovery of cardiac function and leakage of creatine kinase were compared with results in noncardioplegic control hearts. Good protection was observed with the St. Thomas' Hospital and Tyers solutions: The postischemic recovery of cardiac output was increased from 21.2% +/- 12.7% in the cardioplegia-free group to 79.4% +/- 6.2% and 72.9% +/- 4.4%, respectively, in the St. Thomas' Hospital and Tyers groups (p less than 0.01). In contrast, no protection was observed with either the Bretschneider or Rose solutions: Cardiac output recovered to 31.7% +/- 10.3% and 5.1% +/- 3.2%, respectively, in these groups. Postischemic creatine kinase leakage was 72.4 +/- 12.3 and 92.1 +/- 18.6 IU/15 min/gm dry weight in the St. Thomas' Hospital and Tyers groups compared with 125.6 +/- 28.6 IU/15 min/gm dry weight in control hearts (p = no significant difference). In the Bretschneider group, creatine kinase leakage increased to 836.9 +/- 176.8 IU/15 min/gm dry weight (p less than 0.01 versus noncardioplegic control hearts), and with the Roe solution the value was 269.0 +/- 93.0 IU/15 min/gm dry weight (p = no significant difference). In conclusion, cardioplegic protection can be achieved in the immature rabbit myocardium with both St. Thomas' Hospital and Tyers solutions, but acalcemic solutions such as Bretschneider and Roe solutions (which may be effective in the adult heart) increased damage in this preparation. The reported lack of cardioplegic efficacy in the immature myocardium may therefore reflect the choice of cardioplegic solution rather than a greater vulnerability to injury in the neonatal heart.


This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
M. E. Jessen, A. S. Abd-Elfattah, and A. S. Wechsler
Neonatal Myocardial Oxygen Consumption During Ventricular Fibrillation, Hypothermia, and Potassium Arrest
Ann. Thorac. Surg., January 1, 1996; 61(1): 82 - 87.
[Abstract] [Full Text]


Home page
Ann. Thorac. Surg.Home page
J. W. Hammon Jr
Myocardial Protection in the Immature Heart
Ann. Thorac. Surg., September 1, 1995; 60(3): 839 - 842.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
M. Aoki, F. Nomura, and J. E. Mayer Jr.
Interactions between preischemic hypothermia and cardioplegic solutions in the neonatal lamb heart
J. Thorac. Cardiovasc. Surg., March 1, 1994; 107(3): 822 - 828.
[Abstract] [Full Text]


Home page
PerfusionHome page
A. Corno, R. Motterlini, L. Brenna, F. Santoro, and M. Samaja
Ischaemia/reperfusion in the posthypoxaemic re-oxygenated myocardium: haemodynamic study in the isolated perfused rat heart
Perfusion, January 1, 1993; 8(1): 113 - 118.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 1989 by The American Association for Thoracic Surgery.